Nanopin Technologies, Inc
Our mission is to advance infectious disease diagnosis and improve patient care using novel diagnostic platforms that produces rapid and accurate results from patient samples. Our versatile platforms address critical needs for current infectious disease epidemics such as tuberculosis, HIV, and non-tuberculosis mycobacteria (NTM). NanoPin is currently offering diagnostic services for active Tuberculosis in our CLIA facility. Our NanoDetect-TB assay is direct-in-blood and enables early and accurate detection of active TB in any body - infant, young children, or adult, previously BCG vaccinated, and HIV co-infected. The assay is uniquely capable in extrapulmonary TB.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Nanopin Technologies, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Nanopin Technologies, Inc
2 distinct titles indexed · top 2 shown.
- 1ceo
- 1director of product development
Sign up to unlock all 2 contacts at Nanopin Technologies, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Nanopin Technologies, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.